University of Virginia: Q&A - What Drug is the FDA Reviewing to Treat Parkinson's Disease?
October 29, 2025
October 29, 2025
CHARLOTTESVILLE, Virginia, Oct. 29 -- The University of Virginia issued the following Q&A on Oct. 28, 2025, by Zeina Mohammed with Richard Mailman, a professor of pharmacology and neuroscience:
* * *
Q&A: What new drug is the FDA reviewing to treat Parkinson's disease?
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements. . . .
* * *
Q&A: What new drug is the FDA reviewing to treat Parkinson's disease?
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements. . . .